• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌性丝氨酸/苏氨酸激酶Pim-1直接磷酸化并激活G2/M特异性磷酸酶Cdc25C。

The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.

作者信息

Bachmann Malte, Kosan Christian, Xing Pei Xiang, Montenarh Mathias, Hoffmann Ingrid, Möröy Tarik

机构信息

Institut für Zellbiologie (Tumorforschung), IFZ, Universitätsklinikum Essen, Virchowstrasse 173, D-45122 Essen, Germany.

出版信息

Int J Biochem Cell Biol. 2006 Mar;38(3):430-43. doi: 10.1016/j.biocel.2005.10.010. Epub 2005 Nov 8.

DOI:10.1016/j.biocel.2005.10.010
PMID:16356754
Abstract

The proto-oncogene Pim-1 encodes a serine-threonine kinase which is a downstream effector of cytokine signaling and can enhance cell cycle progression by altering the activity of several cell cycle regulators among them the G1 specific inhibitor p21(Waf), the phosphatase Cdc25A and the kinase C-TAK1. Here, we demonstrate by using biochemical assays that Pim-1 can interact with the phosphatase Cdc25C and is able to directly phosphorylate the N-terminal region of the protein. Cdc25C is functionally related to Cdc25A but acts specifically at the G2/M cell cycle transition point and can be inactivated by C-TAK1-mediated phosphorylation. Immuno-fluorescence experiments showed that Pim-1 and Cdc25C co-localize in the cytoplasm of both epithelial and myeloid cells. We find that phosphorylation by Pim-1 enhances the phosphatase activity of Cdc25C and in transfected cells that are arrested in G2/M by bleomycin, Pim-1 can enhance progression into G1. Therefore, we propose that Pim-1 activates Cdc25C by a direct phosphorylation and can thereby assume the function of a positive cell cycle regulator at the G2/M transition.

摘要

原癌基因Pim-1编码一种丝氨酸-苏氨酸激酶,它是细胞因子信号传导的下游效应器,可通过改变几种细胞周期调节因子的活性来促进细胞周期进程,这些调节因子包括G1特异性抑制剂p21(Waf)、磷酸酶Cdc25A和激酶C-TAK1。在此,我们通过生化分析证明,Pim-1可与磷酸酶Cdc25C相互作用,并能够直接磷酸化该蛋白的N端区域。Cdc25C在功能上与Cdc25A相关,但在G2/M细胞周期转换点发挥特异性作用,并且可被C-TAK1介导的磷酸化作用失活。免疫荧光实验表明,Pim-1和Cdc25C在上皮细胞和髓样细胞的细胞质中共定位。我们发现,Pim-1介导的磷酸化作用增强了Cdc25C的磷酸酶活性,在因博来霉素而停滞于G2/M期的转染细胞中,Pim-1可促进细胞进入G1期。因此,我们提出Pim-1通过直接磷酸化作用激活Cdc25C,从而在G2/M转换过程中发挥正向细胞周期调节因子的功能。

相似文献

1
The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.致癌性丝氨酸/苏氨酸激酶Pim-1直接磷酸化并激活G2/M特异性磷酸酶Cdc25C。
Int J Biochem Cell Biol. 2006 Mar;38(3):430-43. doi: 10.1016/j.biocel.2005.10.010. Epub 2005 Nov 8.
2
The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint.致癌性丝氨酸/苏氨酸激酶Pim-1可磷酸化并抑制Cdc25C相关激酶1(C-TAK1)的活性:Pim-1在G2/M细胞周期检查点的新作用。
J Biol Chem. 2004 Nov 12;279(46):48319-28. doi: 10.1074/jbc.M404440200. Epub 2004 Aug 19.
3
The physical association and phosphorylation of Cdc25C protein phosphatase by Prk.Prk对Cdc25C蛋白磷酸酶的物理结合及磷酸化作用。
Oncogene. 1999 Oct 28;18(44):6029-36. doi: 10.1038/sj.onc.1202983.
4
C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.C-TAK1蛋白激酶使人类Cdc25C的丝氨酸216位点发生磷酸化,并促进14-3-3蛋白结合。
Cell Growth Differ. 1998 Mar;9(3):197-208.
5
Mutation of a CK2 phosphorylation site in cdc25C impairs importin alpha/beta binding and results in cytoplasmic retention.细胞分裂周期蛋白25C(cdc25C)中CK2磷酸化位点的突变会损害输入蛋白α/β的结合,并导致其在细胞质中滞留。
Oncogene. 2004 May 20;23(23):4155-65. doi: 10.1038/sj.onc.1207566.
6
Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation.Plk3对Cdc25C丝氨酸191位点的磷酸化促进其核转位。
Oncogene. 2004 Apr 8;23(15):2658-63. doi: 10.1038/sj.onc.1207425.
7
Involvement of protein kinase PKN1 in G2/M delay caused by arsenite.蛋白激酶PKN1参与亚砷酸盐引起的G2/M期阻滞。
Mol Carcinog. 2005 May;43(1):1-12. doi: 10.1002/mc.20087.
8
Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.Pim-1激酶通过在促凋亡蛋白Bad的Ser112守门位点使其磷酸化,促进其失活。
FEBS Lett. 2004 Jul 30;571(1-3):43-9. doi: 10.1016/j.febslet.2004.06.050.
9
The G2/M checkpoint phosphatase cdc25C is located within centrosomes.G2/M 期检验点磷酸酶 cdc25C 位于中心体内。
Int J Biochem Cell Biol. 2007;39(9):1707-13. doi: 10.1016/j.biocel.2007.04.022. Epub 2007 May 3.
10
Pim-1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage.Pim-1 激酶作为细胞周期通路的激活剂,在 DNA 损伤诱导的神经元死亡中发挥作用。
J Neurochem. 2010 Jan;112(2):497-510. doi: 10.1111/j.1471-4159.2009.06476.x. Epub 2009 Nov 6.

引用本文的文献

1
Dual Targeting of Pim and PI3 Kinases in Mature T-Cell Lymphoma.成熟T细胞淋巴瘤中Pim激酶和PI3激酶的双重靶向作用
Eur J Haematol. 2025 Jul;115(1):82-95. doi: 10.1111/ejh.14420. Epub 2025 Mar 31.
2
Unravelling the potency of the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with -arylamide hybrids as PIM-1 kinase inhibitors: synthesis, biological activity and studies.探索以-芳基酰胺杂化物作为PIM-1激酶抑制剂的4-氧代-2-硫代-1,2,3,4-四氢嘧啶-5-甲腈支架的效力:合成、生物活性及研究
RSC Med Chem. 2025 Mar 28. doi: 10.1039/d5md00021a.
3
Pim Kinases: Important Regulators of Cardiovascular Disease.
Pim 激酶:心血管疾病的重要调节因子。
Int J Mol Sci. 2023 Jul 18;24(14):11582. doi: 10.3390/ijms241411582.
4
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma.开发针对T细胞急性淋巴细胞白血病/淋巴瘤的靶向疗法。
Curr Hematol Malig Rep. 2023 Dec;18(6):217-225. doi: 10.1007/s11899-023-00706-7. Epub 2023 Jul 25.
5
Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids.终结者还是守护者?查耳酮-磺酰胺杂化物的设计、合成及细胞毒性分析
ACS Omega. 2023 Feb 17;8(8):7666-7683. doi: 10.1021/acsomega.2c07285. eCollection 2023 Feb 28.
6
Targeting Pim kinases in hematological cancers: molecular and clinical review.靶向血液系统恶性肿瘤的 Pim 激酶:分子与临床综述。
Mol Cancer. 2023 Jan 25;22(1):18. doi: 10.1186/s12943-023-01721-1.
7
Antitumor activity of the protein kinase inhibitor 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines.蛋白激酶抑制剂 1-(β-D-2'-脱氧呋喃核糖基)-4,5,6,7-四溴-1H-苯并咪唑在乳腺癌细胞系中的抗肿瘤活性。
BMC Cancer. 2022 Oct 15;22(1):1069. doi: 10.1186/s12885-022-10156-8.
8
Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.针对多房棘球蚴 PIM 激酶提高抗寄生虫化疗效果。
PLoS Negl Trop Dis. 2022 Oct 3;16(10):e0010483. doi: 10.1371/journal.pntd.0010483. eCollection 2022 Oct.
9
The Role of PIM Kinases in Pediatric Solid Tumors.PIM激酶在儿童实体瘤中的作用。
Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565.
10
Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics.Pim-1 在人类癌症中的临床意义:预后和临床病理特征关联的荟萃分析。
Cancer Control. 2022 Jan-Dec;29:10732748221106268. doi: 10.1177/10732748221106268.